Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/302% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Capital Expenditures — Oral Tobacco Products by Quarter
Capital Expenditures — Oral Tobacco Products ($M) ($M)
Altria Capital Expenditures — Oral Tobacco Products: $44M in Q3 2026, up 120.0% from a year earlier. That is the highest of the 11 quarters on record here.
Latest, Q3 2026
44
Period ended Sep 30, 2026
Change on a year earlier
+120.0%
20 in Q3 2025
History
11 quarters
Since Q1 2024
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
“|| Oral tobacco products | 96 | 42 | 44 | 20”
Source: Altria Form 10-Q (0000764180-26-000114), filed 2026-10-29 ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Capital Expenditures — Oral Tobacco Products ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/seg-capex-oral
See every metric in the Altria KPI table. Data updated Nov 2, 2026.